FIELD: medical chemistry.
SUBSTANCE: tetrahydroisoquinoline compound as a potassium channel modulator, its preparation and application. The invention relates to new tetrahydroisoquinoline compounds represented by formula (A), their preparation and use as a potassium channel modulator.
EFFECT: new compounds suitable for the prevention and/or treatment of diseases that respond to the activity of potassium channels.
10 cl, 7 tbl, 192 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOUND WITH NEUROPROTECTOR ACTION, A METHOD OF ITS PRODUCTION AND ITS USE | 2020 |
|
RU2802457C1 |
| COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS OF 2-AMINOPYRIMIDINE AND THEIR USE | 2020 |
|
RU2795914C1 |
| POLYCYCLIC COMPOUND ACTING AS KINASE INHIBITOR | 2021 |
|
RU2826488C1 |
| PYRROLIDINE DERIVATIVES AS PPAR AGONISTS | 2017 |
|
RU2711991C1 |
| 2,3-DIHYDRO-1H-PYRROLISINE-7-FORMAMIDE DERIVATIVE AND ITS APPLICATIONS | 2019 |
|
RU2792726C2 |
| HALOGENALLILAMINE DERIVATIVES AND THEIR APPLICATIONS | 2020 |
|
RU2793850C2 |
| COMPOUNDS, COMPOSITIONS AND METHODS FOR INCREASING CFTR ACTIVITY | 2015 |
|
RU2767460C2 |
| TRIAZOLE DERIVATIVES, METHOD OF PREPARING THEREOF INSECTICIDAL AND ACARICIDAL AGENT | 1994 |
|
RU2131421C1 |
| COMPOUNDS AND METHODS FOR TREATMENT OF PARASITIC DISEASES | 2018 |
|
RU2793122C2 |
| NOVEL AGONIST OF β-RECEPTOR OF THYROID HORMONES | 2021 |
|
RU2839610C1 |
